Practically focusing on the needs of the medical oncologist, obstetrician, and
gynecologist, this source analyzes the epidemiological, biological, and clinical
issues associated with hereditary breast cancer, and offers clear guidance on
the application and utilization of cancer risk assessment models, screening
options for individuals with HBS, and the identification of high-risk patients.
Addressing every essential aspect of HBC, this source offers succinct analyses
of HBC-associated syndromes, low penetrance genes, and mutations of the BRCA 1
and BRCA 2 genes.